ApprovalTrail

Approval · Notice of Compliance 16541 · 2015

OLIMEL 3.3% E: Notice of Compliance 16541

Issued January 20, 2015

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
16541
Date
January 20, 2015
Company
Baxter CorporationMississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Changes to shelf life specifications
Therapeutic class
Intravenous nutritive supplements

Products in this notice

BrandDINStatus today
OLIMEL 3.3% ENot yet assigned—
OLIMEL 4.4%Not yet assigned—
OLIMEL 4.4% ENot yet assigned—
OLIMEL 5.7%Not yet assigned—
OLIMEL 5.7% ENot yet assigned—
PERIOLIMEL 2.5% ENot yet assigned—

Medicinal ingredients